Atillasoy Ercem
- SEC CIK
- 0001818802
No open-market purchases or sales filed in the past year.
Current role at each company
- KLRS Kalaris Therapeutics, Inc.See Remarksas of Oct 26, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Atillasoy Ercem as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 26, 2022 (view filing) | Oct 20-21 | 6 days | Atillasoy ErcemSee Remarks | SSale | −2.10K | $8.72 | −$18.3K | −1.6%131.4K after | Amended2 lots |
| Jul 22, 2022 (view filing) | Jul 21 | 1 day | Atillasoy ErcemSee Remarks | SSale | −1.53K | $5.38 | −$8.25K | −1.1%133.5K after | |
| Jul 21, 2022 (view filing) | Jul 20 | 1 day | Atillasoy ErcemSee Remarks | SSale | −563 | $5.21 | −$2.93K | −0.4%135.0K after | |
| Apr 22, 2022 (view filing) | Apr 20-21 | 2 days | Atillasoy ErcemSee Remarks | SSale | −2.04K | $6.04 | −$12.3K | −1.7%121.6K after | 2 lots |
| Jan 26, 2022 (view filing) | Jan 25 | 1 day | Atillasoy ErcemSee Remarks | SSale | −4.64K | $8.24 | −$38.2K | −4.4%100.3K after | |
| Oct 25, 2021 (view filing) | Oct 21 | 4 days | Atillasoy ErcemSee Remarks | SSale | −1.51K | $24.23 | −$36.7K | −1.4%105.0K after |